Cargando…
P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430025/ http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d |
_version_ | 1784779630996094976 |
---|---|
author | Harrington, P. Saunders, J. Saha, C. Sheikh, A. Dillon, R. Raj, K. Cadman-Davies, L. Lechmere, T. Khan, H. Woodley, C. Asirvatham, S. Curto-Garcia, N. O’Sullivan, J. Kordasti, S. Radia, D. McLornan, D. Malim, M. Doores, K. Harrison, C. de Lavallade, H. |
author_facet | Harrington, P. Saunders, J. Saha, C. Sheikh, A. Dillon, R. Raj, K. Cadman-Davies, L. Lechmere, T. Khan, H. Woodley, C. Asirvatham, S. Curto-Garcia, N. O’Sullivan, J. Kordasti, S. Radia, D. McLornan, D. Malim, M. Doores, K. Harrison, C. de Lavallade, H. |
author_sort | Harrington, P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9430025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94300252022-08-31 P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS Harrington, P. Saunders, J. Saha, C. Sheikh, A. Dillon, R. Raj, K. Cadman-Davies, L. Lechmere, T. Khan, H. Woodley, C. Asirvatham, S. Curto-Garcia, N. O’Sullivan, J. Kordasti, S. Radia, D. McLornan, D. Malim, M. Doores, K. Harrison, C. de Lavallade, H. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430025/ http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Harrington, P. Saunders, J. Saha, C. Sheikh, A. Dillon, R. Raj, K. Cadman-Davies, L. Lechmere, T. Khan, H. Woodley, C. Asirvatham, S. Curto-Garcia, N. O’Sullivan, J. Kordasti, S. Radia, D. McLornan, D. Malim, M. Doores, K. Harrison, C. de Lavallade, H. P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title | P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title_full | P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title_fullStr | P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title_full_unstemmed | P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title_short | P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS |
title_sort | p990: t cell response and omicron variant neutralisation following vaccination against sars-cov-2 in patients with chronic myeloid disorders |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430025/ http://dx.doi.org/10.1097/01.HS9.0000846828.97717.5d |
work_keys_str_mv | AT harringtonp p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT saundersj p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT sahac p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT sheikha p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT dillonr p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT rajk p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT cadmandaviesl p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT lechmeret p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT khanh p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT woodleyc p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT asirvathams p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT curtogarcian p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT osullivanj p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT kordastis p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT radiad p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT mclornand p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT malimm p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT dooresk p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT harrisonc p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders AT delavalladeh p990tcellresponseandomicronvariantneutralisationfollowingvaccinationagainstsarscov2inpatientswithchronicmyeloiddisorders |